1,5-benzodiazepine derivatives

Details for Australian Patent Application No. 2004201385 (hide)

Owner Glaxo Group Limited

Inventors Colclough, David; Szewczyk, Jerzy Ryszard; Hodgson, Anne

Agent Davies Collison Cave

Pub. Number AU-A-2004201385

Parent 47548

Filing date 1 April 2004

Wipo publication date 29 April 2004

International Classifications

C07D 243/12 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

A61P 003/04 Drugs for disorders of the metabolism

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

22 April 2004 Complete Application Filed

29 April 2004 Application Open to Public Inspection

  Published as AU-A-2004201385

1 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201386-5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction

2004201384-Technology for improving STP protocols in Ethernet networks supporting VLANS